Arushi Singh is a Cardiology physician. OpenAlex indexes 54 publications with 221 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
675 N Saint Clair St Ste 18-200
Chicago, IL 606115929
Telephone
312-695-8630Provider last certified this registry record 26 Aug 2025.
Industry payments
11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year202526 payments
- AOP Health US, LLCProgram year20251 payment
- BridgeBio Pharma, Inc.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
73.4%Beta blocker19%Metoprolol Succinate77%Carvedilol23%Part D<11 patientsStatin15.2%Atorvastatin Calcium67%Rosuvastatin Calcium33%Part D<11 patients+ 6 more classes in this area
Metabolism & gastrointestinal
13.5%SGLT2 inhibitor13.5%Jardiance100%Part D≥13 patientsBlood & clotting
13.2%Factor Xa inhibitor13.2%Eliquis100%Part D≥12 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Percutaneous Coronary Intervention for Heart Failure due to Coronary Artery Disease
Heart Failure Clinics
2025 - Quantitative Characterization of Late Gadolinium Enhancement on Cardiac Magnetic Resonance Imaging to Enhance Diagnosis of Cardiac Sarcoidosis
Journal of Cardiac Failure - Intersections
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”